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Polysaccharides are promising candidates for manufacturing biocompatible core–shell nanoparticles
with potential in vivo use. Superparamagnetic magnetite nanoparticles (MNPs) have prospective appli-
cation in both diagnosis and therapy, and so developing a novel polysaccharide shell on MNP core is of
great challenge. MNPs were prepared by co-precipitation, then the surface of puriﬁed MNPs was coated
with chondroitin-sulfate-A (CSA) to obtain core–shell structured magnetite nanoparticles (CSA@MNP).
The effect of the added amount of CSA on the surface charging and the aggregation state of MNPs at
various pHs and 10 mM NaCl was measured by electrophoresis and dynamic light scattering. The am-
photeric behavior of MNPs was fundamentally modiﬁed by adsorption of CSA polyanions. A very low
CSA-loading induces the aggregation of MNPs, while four times more stabilizes the dispersions over the
whole pH-range studied. The coagulation kinetics experiments measured at pH¼6.370.3 showed that
salt tolerance of CSA@MNPs rises up to 150 mM NaCl.
& 2014 Elsevier B.V. All rights reserved.1. Introduction
Superparamagnetic iron oxide (magnetite, Fe3O4 and maghe-
mite, γ-Fe2O3) nanoparticles (SPIONs) are in the focus of scientiﬁc
interest because of their potential biomedical applications such as
MRI contrasting, targeted drug delivery and magnetic hy-
perthermia [1–6]. Most of these applications require the SPIONs to
be non-toxic, chemically stable, sufﬁciently uniform in size, and
well-dispersed in aqueous media. The colloidal stability of water-
based magnetic ﬂuids (MFs) prepared from SPIONs is of crucial
importance under physiological conditions (e.g. in blood pH7.2–
7.4 and salt concentration 150 mM) because particle aggregation
in blood vessels can be disastrous [1–7]. The SPIONs must be
coated to prevent aggregation and dissolution of magnetite na-
noparticles (MNPs) under physiological conditions [3]. Different
organic compounds have been used to coat SPIONs, such as neu-
tral polymers (e.g. natural dextran [8–11]) and polyelectrolytes
(e.g. synthetic polyacrylic acid [8,12–14]). Innumerable SPION
preparations have been synthesized for biomedical applications,I.Y. Tóth),but only a few of them were characterized systematically in re-
spect of pH-dependent surface charging and aggregation state of
coated nanoparticles. Moreover, their salt tolerance would be also
important regarding the salty medium and different pH values in
the human body.
Dextran- and modiﬁed dextran-coated iron oxide nanoparticles
are very common magnetic products for biocompatible applica-
tions (e.g., Ferumoxides (Feridex or Endorem), Ferumoxtran-10
(Sinerem or Combidex), Ferucarbotran (Resovist) [14,15]). Other
polysaccharides are frequently used as coating agents [16], too.
One example is chondroitin-sulfate (CS), patented under US
5427767 A [17] and EP-1-433-482-B1 [18]. Chondroitin-sulfate is a
natural polysaccharide, which contains a repeating unit of one
glucuronic acid and one N-acetyl-galactoseamine, modiﬁed by
sulfate groups replacing –OH groups. Depending on the positions
and the quantities of the sulfate groups several types of CS can be
distinguished, such as chondroitin-sulfate-A (CSA, chondroitin-4-
sulfate) and chondroitin-sulfate-C (CSC, chondroitin-6-sulfate)
[19] (see Fig. 1). The procedure of magnetic nanoparticle pre-
paration in the presence of CS for potential MRI contrast agents
has been patented [17]. Magnetic microspheres with CS-content
are offered to use for magnetic targeting [20]. Furthermore, there
is a potential for drug delivery, since some promising anticancer
drugs, such as multivalent pseudopeptide, bind to chondroitin-
sulfate with high afﬁnity [21]. Based on all these, well-deﬁned
chondroitin-sulfate-coated core–shell magnetite nanoparticles can
be promising candidate for theranostic application.
Fig. 1. The repeating unit of fully deprotonated CSA and CSC.
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novel chondroitin-sulfate-coated core–shell magnetite nano-
particles (CSA@MNP) by post-coating method, which are pre-
sumably stable colloidally under physiological condition. We in-
tend to synthesize magnetite nanoparticles by co-precipitation
method and to coat them after their puriﬁcation and character-
ization. We plan to describe the adsorption of CSA on magnetite
and to study the pH-dependent surface charging and aggregation
of the CSA@MNP particles. Finally we intend to test the feasibility
of the prepared CSA@MNPs in biorelevant media by coagulation
kinetics studies.2. Experimental section
2.1. Materials
The FeCl2, FeCl3 salts and NaOH for magnetite synthesis by co-
precipitation [22–26] were analytical grade reagents obtained
from Molar, Hungary. The prepared material was puriﬁed carefully
through washing and dialysis, and it was stored as stable sol at
pH3 and 4 °C.
The chondroitin-sulfate-A (CSA) was purchased from Sigma-
Aldrich as sodium-salt (Na2CSA), which could contain a small
amount of chondroitin-sulfate-C (CSC), too. One repeating unit of
CSA (Fig. 1) contains one –COOH and one –SO3H group. The
strongly acidic sulfate groups (–SO3–) in CSA are fully deproto-
nated at a wide pH-range [27,28]. However, the –COOH groups in
CSA have a pH-dependent dissociation (pKβ-glucuronic acid2.9) [29]
given by Eq. (1).
COOH2COOþHþ (1)
The notation “CSA” is used in this article for sodium-salt re-
gardless of the actual degree of dissociation of the carboxylic
groups α¼[COO]/([COO]þ[COOH]). The amount of CSA
is expressed through the mole of repeating units, which equals to
the number of dissociable –COOH groups.
NaCl, HCl and NaOH, analytical grade products of Molar
(Hungary) were used to adjust the pH and salt concentration in all
experiments. Ultra pure water from a Milli-Q RG water puriﬁcation
system (Millipore) was used. All measurements were performed at
2571 °C.
2.2. X-ray diffraction (XRD)
A Bruker D8 Advance X-ray diffractometer operating in the
reﬂection mode with Cu-Kα radiation was used to take the XRD
patterns of synthesized iron oxides. The scanning range of 2Θ was
between 20° and 80°. The samples of magnetite sol were dried on
a glass holder before the measurements. The identiﬁcation ofmagnetite was based on the characteristic peaks in the diffracto-
grams using JCPDS database. The Scherrer equation (see Eq. (2))
was used to calculate the primary particle size:
λ Θ=d K B( )/( cos ) (2)
where d is the average particle size, K is the Scherrer constant (its
value is 0.9 for magnetite), λ is the X-ray wavelength (0.154 nm), B
is the peak broadening and Θ is the position of the peak
maximum.2.3. Magnetic measurement
A vibrating sample magnetometer VSM 880 (DMS/ADE Tech-
nologies-USA) was used to measure the magnetization curves at
the NCESCF-UP Timisoara. The analysis was performed at room
temperature on stable aqueous MNP sol at 10% by weight; the
maximum of the applied ﬁeld was 840 kA/m. The value of spe-
ciﬁc magnetization was related to the actual amount of MNP.2.4. Transmission electron microscopy (TEM)
A Philips CM-10 transmission electron microscope supplied
with a Megaview-II camera was used to take the TEM micrographs
of iron oxide nanoparticles. The accelerating voltage of 100 kV was
applied; the maximum resolution of the instrument is 0.2 nm. One
drop of highly diluted magnetite sol was dried on to Formwar-
coated copper under infrared lamp. The average size distribution
was determined by evaluating 100 particles using the JMicroVision
1.2.7 software.2.5. Surface modiﬁcation of MNPs
The surface of the puriﬁed, bare magnetite was modiﬁed by
chondroitin-sulfate-A to prepare core-shell nanoparticles. The ef-
fect of the CSA-adsorption on the particle interaction was de-
termined ﬁrst in concentrated systems at pH¼6.370.3 and
10 mM NaCl. The MNPs were equilibrated for 24 h with CSA so-
lutions of concentration between 0 and 10 mM at a solid/liquid
ratio of 20 g/L. The pH was adjusted at the beginning of adsorp-
tion. The adsorption series was evaluated after a day.2.6. Particle size determination
For characterization of the aggregation state of nanoparticles,
the average hydrodynamic diameter (Z-Ave) of bare magnetite
particles and of CSA-coated nanoparticles were determined at
2570.1 °C using dynamic light scattering (DLS) method, an ap-
paratus Nano ZS (Malvern) with a 4 mW HeNe laser source
(λ¼633 nm) operating in backscattering mode at an angle of 173°.
The dispersions were diluted to get an optimal intensity of 105
counts per s, thus the samples contained 100 mg/L of magnetite.
Prior to the measurements, the samples were homogenized in an
ultrasonic bath for 10 s, after which 2 min relaxation was allowed.
Any changes in the aggregation state of the bare or the CSA-coated
nanoparticles in aqueous dispersions was characterized by the
hydrodynamic diameter (Z-Ave). The inﬂuence of the added CSA
amount was determined at pH¼6.370.3 and 10 mM NaCl. The
effect of pH variation (between 3 and 10) at different CSA-loadings
(0.0, 0.05, 0.1, 0.2, and 0.4 mmol/g) was studied at 10 mM NaCl.
For evaluation, we used the second- or third-order cumulant
ﬁt of the autocorrelation functions, depending on the degree of
polydispersity.
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Electrophoretic mobilities of the pure magnetite and CSA@MNP
dispersions were measured at 2570.1 °C in the same Nano ZS
(Malvern) apparatus using disposable zeta cells (DTS 1060). The
zeta-standard of Malvern (5575 mV) was used for calibration.
The added amounts of CSA, the pH-range, and the ionic strength
were identical to those in the DLS experiments. The Smoluchowski
equation was applied to convert electrophoretic mobilities to
electrokinetic potential values. The accuracy of the measurements
was 75 mV.
2.8. Salt tolerance tests
The CSA-adsorption can change the colloidal stability of the
magnetite nanoparticles and this process can be tested accurately
in coagulation kinetics experiments. These measurements were
performed at different NaCl concentrations, 2570.1 °C,
pH¼6.370.3 and 0.2 mmol/g CSA-loading. The change in the
hydrodynamic diameter of kinetic units (Z-Ave) was measured by
DLS for 15 min; the resolution was 1 min. At a given NaCl con-
centration, the measured Z-Ave data were plotted as a function of
time. The initial slope of the curve is proportional to the coagu-
lation rate [30,31] and the ratio of the fast and slow coagulation
rates results in the stability ratio (W). The critical coagulation
concentration (CCC) was determined from the stability plot (the
dependence of the stability ratio on the NaCl concentration, log10
W¼ f(log10 c) [22,23]) as the intersection point of straight lines
ﬁtted to the experimental log10 W values belonging to the slow
and fast coagulation regimes.
The majority of the experiments were performed at
pH¼6.370.3 and 10 mM NaCl. For the sake of simplicity, we take
this pH value as pH6.3 and omit the indication of pH and NaCl
concentration unless it has special signiﬁcance or the values are
different.3. Results and discussion
3.1. Characterization of the prepared magnetite nanoparticles
XRD, TEM and VSM methods were used to characterize the
crystalline phase, the primary particle size and the magnetic
property of the prepared iron oxide particles. The results can be
seen in Fig. 2a–c.
The X-ray diffractogram (Fig. 2a) shows the crystalline struc-
ture of the synthesis product. The typical peaks can be found at
30.1°, 35.5°, 43.2°, 57.0° and 63.0°, which preferably correspond to
the magnetite according to the JCPDS database. The Miller indices
of these peaks are (220), (311), (400), (511) and (440), respectively.
The primary particle size calculated from the peak at 35.5° with
Scherrer equation was about 10 nm. The TEM picture (Fig. 2c) of
the MNPs shows spherical particles and their calculable average
size was around 10 nm, too. The magnetization curve of the naked
MNP (Fig. 2b) shows no hysteresis, and so the magnetic behavior
of the synthesized nanoparticles is superparamagnetic at room
temperature. This property is in a good agreement with the pri-
mary particle size, because the superparamagnetic limit of mag-
netite nanoparticles is 20 nm [32,33]. The value of the saturation
magnetization is 75 emu/g.
The pH-dependent surface charging and aggregation of naked
magnetite were determined by electrokinetic potential and dy-
namic light scattering measurements (Fig. 2d). To understand the
signiﬁcant changes shown in Fig. 2d, ﬁrst the surface charging of
naked MNPs needs to be clariﬁed in general. The surface of mag-
netite becomes charged, when particles are dispersed in aqueousmedia [22,23,32,34–40]. Charges develop on the amphoteric sur-
face hydroxyls (≡Fe–OH) and this process is controlled by both the
pH and the ionic strength of aqueous medium [22,23,41–44]. The
reactions of surface ≡Fe–OH sites with Hþ and OH ions lead to
the formation of positive (≡Fe–OH2þ) and negative (≡Fe–O)
surface charges (see Eqs. (3) and (4)).
≡Fe–OHþHþ2≡Fe–OH2þ (3)≡Fe–OH2≡Fe–OþHþ or ≡Fe–OHþOH2≡Fe–OþH2O (4)
At a characteristic pH, i.e., the pH of isoelectric point (IEP), the
amounts of oppositely charged surface sites are equal to each
other. At pHs lower than the IEP, the charge of MNP is positive due
to the presence of excess ≡Fe–OH2þ groups, while the particles are
negatively charged above the pH of IEP because of the formation of
≡Fe–O– groups, the IEP of magnetite is often in wide pH-range
[32].
As shown on the inserted photos of Fig. 2d, colloidally stable
dispersion of naked magnetite can only be observed at pH values
below 5 or above 10, accompanied by a high absolute value of
electrokinetic potential (þ40 mV or 40 mV) and a low hydro-
dynamic diameter (120 nm), because of the electrostatic stabi-
lization of particles, caused by the presence of either ≡Fe–OH2þ in
the acid range or ≡Fe–O– surface groups in the basic range. The
measured IEP of magnetite nanoparticles, where the electrokinetic
potential of MNPs is zero is at pH8. Around this pH, close to the
physiological conditions (e.g. in blood pH 7.2–7.4), the naked MNPs
are aggregated (the average particle size 1600 nm). In biological
milieu like blood, this would be dangerous because of embolism.
So the pH-range of aggregation must be shifted in order to have a
chance for biomedical applications. Therefore the surface of MNPs
should be modiﬁed to overcome this gap, here we use CSA to coat
MNPs.3.2. CSA-loading of magnetite nanoparticles
The series of magnetite sols loaded with CSA at pH6.3 after
standing for 24 h is presented in Fig. 3. With increasing CSA con-
centration, the colloidal state of samples changes characteristically
from aggregated to stable. In these samples, the solution con-
centration of CSA increases from 0 to 9 mmol/L (expressed
through the molar amount of its repeating units), while its speciﬁc
amount related to 1 g magnetite rises up to 0.45 mmol/g.
To understand this signiﬁcant change shown in Fig. 3, we have
to evaluate the surface charging of naked magnetite at the given
condition, i.e., at the pH6.3 and 10 mM NaCl. Under these con-
ditions the amount of the positive charge on MNPs is
0.05 mmol/g from acid/base titration [12]. This is not enough to
stabilize the particles electrostatically; therefore, the naked MNPs
are aggregated and settled (see the ﬁrst vial in Fig. 3). With in-
creasing CSA-loading, ﬁrstly the CSA@MNP particles are still set-
tled, but above 0.25 mmol/g CSAaddition, the CSA-coated mag-
netite nanoparticles become dispersed (see the sixth vial in Fig. 3).
The CSA@MNP samples seem to be stable at high CSA-loading (see
the last three photos in Fig. 3), but the signs of aggregation (par-
ticles on the glass surface and partial sedimentation) can be seen
even under these conditions. However, stable magnetic ﬂuid can
be prepared from the CSA-coated MNPs by careful addition of CSA
to magnetite sol under vigorous mixing.
Fig. 2. Characterization of the naked magnetite nanoparticles by (a) XRD pattern, (b) speciﬁc magnetization curve, (c) TEM image and by (d) the pH-dependent electrokinetic
potential and average size (Z-Ave) measured at 10 mM NaCl by DLS. (Photos were taken after standing for 24 h, the inserted pictures are the schematic illustration of the
surface charging on MNPs. Lines are drawn as guides for the eye.)
Fig. 3. Series of CSA adsorption on MNP, containing CSA in increasing amount up to
0.45 mmol/g (see the numbers on the vials) at pH6.3 and 10 mM NaCl at a solid/
liquid ratio of 20 g/L. (The amount of CSA is expressed through the molar amount of
repeating units given in mmol, normalized to 1 g magnetite).
Fig. 4. Effect of CSA addition (a) on the electrokinetic potential and average size
(Z-Ave) of MNPs and (b) on the colloidal stability of the dispersions at pH6.3 and
10 mM NaCl (photos were taken after standing for 24 h) in parallel with the
schematic illustration of CSA-coating of particles. (Lines are drawn as guides for the
eye. The amount of CSA is expressed through the molar amount of repeating units
given in mmol.)
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MNPs
The changes in the electrokinetic potential and the average size
(Z-Ave) of the nanoparticles are plotted as a function of CSA addition
in Fig. 4a. A few representative samples are shown in Fig. 4b along
with a schematic illustration of the CSA-coating of particles. As dis-
cussed earlier, the naked magnetite is positively charged at pH6.3
and 10 mM NaCl, the electrokinetic potential of the particles is
þ25 mV, and the sample is aggregated (Z-Ave 1500 nm) and
settled (see the ﬁrst vial in Fig. 4b). The electrokinetic potential de-
clines with the increasing amount of negatively charged CSA due to
the –SO3– and –COO– groups, added gradually to the MNP sols. The
charge neutralization levels at 0.035 mmol/g CSA-loading. This is a
kind of isoelectric point (IEP), where negatively charged CSA patches
exist on the positive MNPs and these patchwise charge heterogeneity
induces particles aggregation and drives the Z-Ave of CSA@MNP
aggregates to a maximum (2300 nm). Further addition of chon-
droitin-sulfate-A caused charge reversal, decreased the value of
the electrokinetic potential to 45 mV, and brought about the
electrosteric stabilization of CSA@MNP samples (see in Fig. 4a).
The particles become fully dispersed and colloidally stable
(Z-Ave120 nm) at 0.2 mmol/g of CSA addition (see the last vials
in Fig. 4b).The pH-dependent electrokinetic potential, the average particle
size and the photos showing the change in colloidal stability of the
CSA@MNP particles at different CSA-loadings (0.0, 0.05, 0.1,
0.2 and 0.4 mmol/g) can be seen in Fig. 5. The pH-dependent
properties of naked magnetite were already discussed in Section
3.1. Adding a small amount of CSA (0.05 mmol/g) to the MNP, the
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over the whole range of pH studied here, due to the patchwise
adsorption of the negatively charged CSA on the originally posi-
tively charged MNP [22,23,45,46]. Increasing amounts of CSA shift
the IEP gradually to a more acidic pH value (Fig. 5a) and narrow
the pH-range of aggregation (Fig. 5b and c). Further addition of
CSA (above 0.2 mmol/g) results in stable MNP dispersion with
low particle size and electrokinetic potential almost over the
whole pH-range studied.90
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The salt tolerance of MNPs coated with 0.2 mmol CSA/g was
studied in coagulation kinetics experiments at pH6.3. The par-
ticle size evolution was followed in time by DLS experiments (see
Fig. 6a) and the calculated stability ratios (log10 W) are plotted as a
function of NaCl concentration (log10 c) in Fig. 6b. The critical
coagulation concentration (CCC) was determined (see Fig. 6b) to
characterize accurately the salt tolerance of the CSA@MNP0.0
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[12,47], however, the CCC of CSA@MNP at 0.2 mmol/g CSA-loading
is much higher 150 mM owing to the effective polyanionic
coverage of MNP's surface. This CCC value is high enough to enable
the use of CSA@MNP at physiological concentration of NaCl.4. Conclusion
The aim of this work was to prepare novel CSA-coated core–
shell magnetite nanoparticles stable colloidally under physiologi-
cal condition and to characterize the surface coating process and
the surface-properties of the CSA@MNP product as well. The solid
experimental facts allow us to conclude that the CSA@MNP par-
ticles can be prepared, which are electrosterically stabilized at
CSA-loading 40.2 mmol/g over the wide range of pH (44)
matching well with biological medium. The measured CCC guar-
antees that the salt tolerance of CSA@MNP is sufﬁciently high to
resist aggregation in a physiological medium. So the CSA-coated
core–shell magnetite nanoparticles are promising candidates for
biomedical applications like contrast agents in MRI diagnostics or
well deﬁned carriers in drug delivery for anticancer drugs. Fur-
thermore, based on the potential combination of these medical
diagnostic and therapeutic methods, even the theranostic appli-
cation of CSA@MNP products can be feasible.Acknowledgment
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